Spruce Biosciences, Inc.
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -23.18 | -21.01 | -28.00 | -20.75 | -17.18 | -36.72 | -22.28 | -14.56 | -9.44 | -8.42 | -6.36 | -9.10 | -17.53 | |
| 0.03 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | 0.18 | 0.26 | 0.37 | |
| 2.12 | 2.29 | 2.92 | 3.15 | 2.12 | 1.71 | 0.95 | -0.13 | 0.74 | 2.21 | 0.50 | 0.36 | 1.51 | |
| -1.84 | -4.67 | -9.30 | -6.89 | -3.29 | 3.28 | 1.50 | -10.38 | 4.10 | 3.14 | 1.77 | -2.23 | 0.71 | |
| 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.06 | 0.06 | |
| 26.44 | 17.44 | – | – | – | – | – | – | – | – | -0.01 | -0.06 | – | |
| – | -0.41 | 0.00 | -0.02 | – | – | – | – | 0.01 | 0.03 | – | 0.00 | – | |
| – | – | – | – | -0.75 | -0.72 | -0.71 | -0.67 | -0.72 | -1.10 | 10.31 | 0.00 | 5.31 | |
| -0.77 | -1.03 | -0.42 | -0.68 | -0.75 | -1.11 | -0.72 | -0.66 | -0.71 | 58.30 | 10.14 | 26.52 | 50.46 | |
| 2.49 | -4.62 | -28.42 | -21.44 | -17.93 | -37.83 | -23.00 | -15.22 | -10.16 | 49.93 | 3.77 | 17.36 | 32.88 | |
| -23.20 | -21.01 | -28.00 | -20.75 | -17.18 | -36.72 | -22.28 | -14.56 | -9.44 | -8.42 | -6.37 | -9.15 | -17.59 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.